Literature DB >> 20223588

Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation.

Norikazu Kiguchi1, Takehiko Maeda, Yuka Kobayashi, Yohji Fukazawa, Shiroh Kishioka.   

Abstract

In the present study, we investigated the role of the macrophage inflammatory protein-1alpha (MIP-1alpha) in the pathogenesis of neuropathic pain following partial sciatic nerve ligation (PSL) in mice. MIP-1alpha mRNA and its protein were dramatically up-regulated after PSL, and MIP-1alpha was localized on macrophages and Schwann cells in the injured sciatic nerve (SCN). PSL-induced long-lasting tactile allodynia and thermal hyperalgesia were prevented by the perineural injection of anti-MIP-1alpha (2ng). Intraneural (20ng) and perineural (100ng) injection of recombinant MIP-1alpha elicited tactile allodynia and thermal hyperalgesia in sham-operated limb. MIP-1alpha receptors (CCR1 and CCR5) mRNA and their proteins were also up-regulated in the SCN after PSL, and were localized on macrophages and Schwann cells. PSL-induced tactile allodynia was attenuated by perineural injection (0.2nmol) of siRNA against CCR1 and CCR5. On the other hand, PSL-induced thermal hyperalgesia was prevented by siRNA against CCR5, but not CCR1. Interleukin-1beta (IL-1beta) mRNA and its precursor protein in macrophages and Schwann cells were also up-regulated in the SCN after PSL, and PSL-induced neuropathic pain was prevented by the perineural injection of anti-IL-1beta (2ng). PSL-induced IL-1beta up-regulation was suppressed by anti-MIP-1alpha and siRNA against CCR1 and CCR5. Perineural injection of nicotine (20nmol), a macrophage suppressor, prevented PSL-induced neuropathic pain and suppressed MIP-1alpha and IL-1beta expressions. In conclusion, we propose a novel critical molecule MIP-1alpha derived from macrophages and Schwann cells that appears to play a crucial role in the development of neuropathic pain induced by PSL. Copyright 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223588     DOI: 10.1016/j.pain.2010.02.025

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  49 in total

1.  CCL-2 as a possible early marker for remission after traumatic spinal cord injury.

Authors:  R A Heller; T F Raven; T Swing; K Kunzmann; V Daniel; P Haubruck; M Akbar; P A Grützner; G Schmidmaier; B Biglari; A Moghaddam
Journal:  Spinal Cord       Date:  2017-06-20       Impact factor: 2.772

Review 2.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

3.  Experimental autoimmune prostatitis induces microglial activation in the spinal cord.

Authors:  Larry Wong; Joseph D Done; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2014-09-27       Impact factor: 4.104

Review 4.  The Multifunctional Role of the Chemokine System in Arthritogenic Processes.

Authors:  Giovanni Bernardini; Giorgia Benigni; Rossana Scrivo; Guido Valesini; Angela Santoni
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 5.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

6.  Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.

Authors:  Yuka Kobayashi; Norikazu Kiguchi; Yohji Fukazawa; Fumihiro Saika; Takehiko Maeda; Shiroh Kishioka
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

7.  The three isoforms of nitric oxide synthase distinctively affect mouse nocifensive behavior.

Authors:  Julia Finkel; Virginia Guptill; Alfia Khaibullina; Nicholas Spornick; Olavo Vasconcelos; David J Liewehr; Seth M Steinberg; Zenaide M N Quezado
Journal:  Nitric Oxide       Date:  2011-12-17       Impact factor: 4.427

8.  Further evidence on a role of chemokines in injury-related pain hypersensitivity: commentary on a paper by Saika et al. (2012, this issue).

Authors:  Ke Ren
Journal:  Eur J Pain       Date:  2012-05-21       Impact factor: 3.931

Review 9.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

Review 10.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.